Enovix Corp (ENVX) financial statements: income statement, balance sheet and cash flow
Enovix Corp's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 28, 2025 · FY), Enovix Corp reported revenue of $31.8M (+37.9% year on year) and net income of ($156.7M) (+29.5% year on year).
Income statement
Enovix Corp income statement, fiscal years
Line item
Dec 28, 2025 · FY
Dec 29, 2024 · FY
Dec 31, 2023 · FY
Jan 1, 2023 · FY
Revenue
$31.8M
$23.1M
$7.6M
$6.2M
Cost of revenue
$25.7M
$25.1M
$63.1M
$23.2M
Gross profit (loss)
$6.1M
($2.0M)
($55.4M)
($17.0M)
Research and development
$110.3M
$124.5M
$88.4M
$58.1M
Selling, general and administrative
$73.0M
$74.3M
$79.0M
$52.0M
Impairment of equipment
$0
$0
$4.4M
$4.9M
Restructuring cost
$0
$41.8M
$3.0M
—
Total operating expenses
$183.4M
$240.6M
$174.8M
$114.9M
Loss from operations
($177.3M)
($242.7M)
($230.3M)
($132.0M)
Change in fair value of common stock warrants
$21.8M
$12.2M
$6.2M
$75.2M
Gain on bargain purchase of assets
$4.8M
—
—
—
Interest income
$13.0M
$12.3M
$14.1M
—
Interest expense
($21.6M)
($6.8M)
($4.5M)
—
Other income (expense), net
$1.3M
$954.0K
($304.0K)
($54.0K)
Total other income (expense), net
$19.3M
$18.7M
$15.5M
$80.4M
Loss before income tax benefit
($157.9M)
($223.9M)
($214.8M)
—
Income tax benefit
($1.3M)
($1.4M)
($633.0K)
—
Net loss
($156.6M)
($222.5M)
($214.1M)
—
Net gain (loss) attributable to non-controlling interests
$134.0K
($293.0K)
($61.0K)
—
Net loss attributable to Enovix
($156.7M)
($222.2M)
($214.1M)
($51.6M)
Net loss per share attributable to Enovix shareholders, basic (in dollars per share)
-$0.75
-$1.27
-$1.35
-$0.34
Weighted average number of common shares outstanding, basic (in shares)
207.6M
175.0M
159.1M
152.9M
Net loss per share attributable to Enovix shareholders, diluted (in dollars per share)
-$0.75
-$1.27
-$1.38
-$0.82
Weighted average number of common shares outstanding, diluted (in shares)
207.6M
175.0M
159.6M
154.1M
Enovix Corp income statement, quarters
Line item
Jul 5, 2026 · Q3
Apr 5, 2026 · Q2
Sep 28, 2025 · Q3
Jun 29, 2025 · Q2
Total
$9.0M
$7.6M
$8.0M
$7.5M
Cost of revenue
$7.7M
$6.0M
$6.6M
$5.5M
Gross profit
$1.3M
$1.6M
$1.4M
$1.9M
Research and development
$24.4M
$26.5M
$28.2M
$28.1M
Selling, general and administrative
$20.2M
$18.9M
$20.2M
$17.5M
Total operating expenses
$44.6M
$45.4M
$48.4M
$45.7M
Loss from operations
($43.3M)
($43.9M)
($47.0M)
($43.7M)
Change in fair value of common stock warrants
$181.0K
$6.4M
$1.9M
($5.9M)
Gain on bargain purchase of assets
$0
—
$0
$4.8M
Interest income
$5.1M
$5.8M
$2.5M
$2.4M
Interest expense
($6.5M)
($7.0M)
($11.8M)
($1.7M)
Other income (expense), net
$984.0K
$343.0K
$140.0K
($992.0K)
Total other income (expense), net
($222.0K)
$5.5M
($7.2M)
($1.4M)
Loss before income tax benefit
($43.5M)
($38.4M)
($54.2M)
($45.1M)
Income tax benefit
($441.0K)
($129.0K)
($422.0K)
($861.0K)
Net loss
($43.1M)
($38.3M)
($53.8M)
($44.3M)
Net gain (loss) attributable to non-controlling interest
($14.0K)
$2.0K
($56.0K)
$262.0K
Net loss attributable to Enovix
($43.1M)
($38.3M)
($53.7M)
($44.5M)
Net loss per share attributable to Enovix shareholders, basic (in dollars per share)
-$0.20
-$0.18
-$0.26
-$0.22
Net loss per share attributable to Enovix shareholders, diluted (in dollars per share)
-$0.20
-$0.18
-$0.27
-$0.22
Weighted average number of common shares outstanding, basic (in shares)
218.5M
217.4M
206.5M
204.8M
Weighted average number of common shares outstanding, diluted (in shares)
218.5M
217.4M
206.8M
204.8M
Balance sheet
Enovix Corp balance sheet, fiscal years
Line item
Dec 28, 2025 · FY
Dec 29, 2024 · FY
Dec 31, 2023 · FY
Jan 1, 2023 · FY
Cash and cash equivalents
$106.0M
$272.9M
$233.1M
$322.9M
Short-term investments
$406.0M
$0
$73.7M
—
Accounts receivable, net
$4.4M
$4.6M
$909.0K
$170.0K
Notes receivable, net
$4.0M
$4.0K
$1.5M
—
Inventory
$13.6M
$7.7M
$8.7M
$634.0K
Prepaid expenses and other current assets
$8.1M
$9.9M
$5.2M
$5.2M
Total current assets
$542.2M
$295.0M
$323.2M
$329.6M
Property and equipment, net
$170.3M
$167.9M
$166.5M
$103.9M
Long-term investments
$106.8M
—
—
—
Customer relationship intangibles and other intangibles, net
$31.6M
$36.4M
$42.2M
—
Operating lease, right-of-use assets
$11.7M
$13.5M
$15.3M
$6.1M
Goodwill
$12.2M
$12.2M
$12.1M
—
Other assets, non-current
$4.2M
$2.1M
$5.1M
$937.0K
Total assets
$879.0M
$527.2M
$564.3M
$440.6M
Accounts payable
$17.8M
$9.5M
$21.3M
$7.1M
Accrued expenses
$14.0M
$19.8M
$14.0M
$7.1M
Accrued compensation
$6.2M
$8.2M
$10.7M
$8.1M
Short-term debt
$9.9M
$9.5M
$5.9M
—
Deferred revenue
$5.0M
$3.6M
$6.7M
$50.0K
Warrant liability
$6.6M
$28.4M
$42.9M
$49.1M
Other liabilities
$5.5M
$3.0M
$2.4M
$716.0K
Total current liabilities
$65.0M
$53.7M
$61.0M
$23.0M
Long-term debt, net
$519.3M
$169.8M
$169.1M
—
Warrant liability, non-current
$0
—
—
—
Operating lease liabilities, non-current
$11.2M
$13.3M
$15.6M
$8.2M
Deferred revenue, non-current
$300.0K
$3.8M
$3.8M
$3.7M
Deferred tax liability
$9.1M
$8.8M
$10.8M
—
Other liabilities, non-current
$14.0K
$14.0K
$13.0K
$92.0K
Total liabilities
$605.0M
$277.8M
$303.2M
$84.2M
Common stock, $0.0001 par value; authorized shares of 1,000,000,000; issued and outstanding shares of 216,556,238 and 190,559,335 as of December 28, 2025 and December 29, 2024, respectively
22.0K
19.0K
17.0K
15.0K
Additional paid-in-capital
$1.3B
$1.1B
$857.0M
$741.2M
Treasury stock, at cost
($58.4M)
—
—
—
Accumulated other comprehensive loss
($508.0K)
($143.0K)
($62.0K)
—
Accumulated deficit
($977.8M)
($821.1M)
($598.8M)
($384.8M)
Total Enovix's stockholders’ equity
$271.2M
$246.7M
$258.1M
$356.4M
Non-controlling interest
$2.8M
$2.7M
$3.0M
—
Total equity
$274.0M
$249.4M
$261.1M
—
Total liabilities and equity
$879.0M
$527.2M
$564.3M
$440.6M
Enovix Corp balance sheet, quarters
Line item
Jul 5, 2026
Apr 5, 2026
Sep 28, 2025
Jun 29, 2025
Cash and cash equivalents
$33.7M
$88.8M
$335.5M
$136.0M
Short-term investments
$442.0M
$440.0M
$223.3M
$67.4M
Accounts receivable, net
$3.1M
$3.9M
$4.6M
$4.2M
Notes receivable, net
$0
$0
$2.4M
$1.1M
Inventory
$17.5M
$16.5M
$15.2M
$13.4M
Prepaid expenses and other current assets
$9.3M
$9.4M
$7.5M
$6.2M
Total current assets
$505.7M
$558.5M
$588.6M
$228.3M
Property and equipment, net
$165.2M
$165.0M
$174.6M
$177.9M
Long-term investments
$74.4M
$52.1M
$89.5M
—
Customer relationship intangibles and other intangibles, net
$29.2M
$30.4M
$32.8M
$34.0M
Operating lease, right-of-use assets
$8.6M
$11.6M
$11.8M
$12.4M
Goodwill
$12.2M
$12.2M
$12.2M
$12.2M
Other assets, non-current
$4.3M
$4.2M
$4.2M
$4.3M
Total assets
$799.6M
$833.9M
$913.7M
$469.1M
Accounts payable
$12.2M
$14.9M
$21.3M
$13.9M
Accrued expenses
$11.5M
$8.8M
$8.9M
$6.2M
Accrued compensation
$7.6M
$7.6M
$7.2M
$8.3M
Short-term debt
$10.6M
$9.4M
$10.2M
$10.4M
Deferred revenue
$3.7M
$4.3M
$7.7M
$8.1M
Warrant liability
$0
$181.0K
$16.6M
$18.5M
Other liabilities
$6.6M
$5.7M
$5.3M
$5.4M
Total current liabilities
$52.1M
$50.9M
$60.6M
$52.3M
Long-term debt, net
$521.0M
$520.2M
$518.3M
$169.4M
Operating lease liabilities, non-current
$5.9M
$10.9M
$11.4M
$12.2M
Deferred revenue, non-current
$300.0K
$300.0K
$300.0K
$300.0K
Deferred tax liability
$8.3M
$8.9M
$9.3M
$9.8M
Other liabilities, non-current
$13.0K
$14.0K
$14.0K
$15.0K
Total liabilities
$587.6M
$591.2M
$616.6M
$262.5M
Common stock, $0.0001 par value; authorized shares of 1,000,000,000; issued and outstanding shares of $219,195,932 and $216,556,238 as of July 5, 2026 and December 28, 2025, respectively
23.0K
22.0K
22.0K
19.0K
Additional paid-in-capital
$1.3B
$1.3B
$1.3B
$1.1B
Treasury stock, at cost
($58.4M)
($58.4M)
($58.4M)
—
Accumulated other comprehensive loss
($1.4M)
($1.2M)
($658.0K)
($391.0K)
Accumulated deficit
($1.1B)
($1.0B)
($942.8M)
($889.1M)
Total Enovix’s stockholders’ equity
$209.9M
$240.7M
$294.3M
$203.7M
Non-controlling interest
$2.0M
$2.1M
$2.8M
$2.9M
Total equity
$212.0M
$242.7M
$297.1M
$206.7M
Total liabilities and equity
$799.6M
$833.9M
$913.7M
$469.1M
Cash flow statement
Enovix Corp cash flow statement, fiscal years
Line item
Dec 28, 2025 · FY
Dec 29, 2024 · FY
Dec 31, 2023 · FY
Jan 1, 2023 · FY
Net loss
($156.6M)
($222.5M)
($214.1M)
($51.6M)
Depreciation, accretion and amortization
$35.1M
$45.0M
$34.0M
$7.4M
Stock-based compensation
$49.4M
$58.8M
$69.5M
$30.4M
Change in fair value of common stock warrants
($21.8M)
($12.2M)
($6.2M)
($75.2M)
Gain on bargain purchase of assets
($4.8M)
—
—
—
Impairment and loss on disposal of long-lived assets
$0
$38.3M
—
—
Interest expense (non-cash)
$9.2M
—
—
$0
Others
$711.0K
$448.0K
$703.0K
—
Accounts and notes receivables
($3.9M)
($2.5M)
($370.0K)
($170.0K)
Inventory
($5.5M)
$1.1M
$4.5M
($634.0K)
Prepaid expenses and other assets
($85.0K)
($2.2M)
($626.0K)
($2.8M)
Accounts payable
$4.7M
($8.0M)
$6.1M
$2.3M
Accrued expenses and compensation
$1.6M
$3.0M
$2.0M
$2.5M
Deferred revenue
($2.0M)
($3.1M)
($3.9M)
($4.1M)
Deferred tax liability
($1.3M)
($2.7M)
($813.0K)
—
Other liabilities
$75.0K
($2.0M)
$188.0K
($48.0K)
Net cash used in operating activities
($95.3M)
($108.6M)
($104.6M)
($82.7M)
Purchase of property and equipment
($18.2M)
($76.2M)
($61.8M)
($36.2M)
Payment for business acquisition
($10.0M)
—
—
—
Routejade acquisition, net of cash and restricted cash acquired
$0
$0
($10.0M)
—
Purchases of investments
($584.9M)
($31.8M)
($138.3M)
—
Maturities of investments
$74.9M
$106.6M
$67.2M
—
Net cash used in investing activities
($538.3M)
($1.4M)
($143.0M)
($36.2M)
Proceeds from issuance of common stock, net of issuance costs
$0
$107.2M
—
—
Proceeds from exercise of common stock warrants
$232.1M
$0
$0
$52.8M
Payments of issuance costs related to common stock and warrant dividends
($7.1M)
—
—
—
Proceeds from issuance of convertible senior notes and loan borrowing
$360.0M
—
—
—
Payments of debt issuance costs
($11.2M)
$0
($5.9M)
$0
Purchase of Capped Calls
($45.3M)
$0
($17.3M)
—
Repayment of debt
($919.0K)
($209.0K)
($69.0K)
$0
Proceeds from issuance of common stock under employee stock purchase plan
1.3M
1.5M
2.4M
1.9M
Payroll tax payments for shares withheld upon vesting of RSUs
-6.5M
-7.1M
-3.9M
-587.0K
Proceeds from the exercise of stock options and issuance of common stock under ATM, net of issuance costs
$3.3M
$44.8M
$11.9M
$2.4M
Repurchase of unvested restricted common stock
$0
—
—
—
Repurchase of common stock
($58.4M)
($4.0K)
($26.0K)
($10.0K)
Net cash provided by financing activities
$467.4M
$150.7M
$159.6M
$56.5M
Effect of exchange rate changes on cash, cash equivalents and restricted cash
($536.0K)
($1.2M)
$154.0K
—
Change in cash, cash equivalents, and restricted cash
($166.7M)
$39.6M
($87.9M)
($62.4M)
Cash and cash equivalents and restricted cash, beginning of period
$274.7M
$235.1M
$323.0M
$385.4M
Cash and cash equivalents and restricted cash, end of period
$108.0M
$274.7M
$235.1M
$323.0M
Cash paid for interest
$5.7M
$5.7M
$2.8M
—
Cash paid for income taxes
$1.1M
$185.0K
—
—
Purchase of property and equipment included in liabilities
$10.2M
$13.0M
$16.0M
$7.0M
Cashless warrant exercise
$0
$2.3M
—
—
Accrued issuance costs
$0
$512.0K
—
—
Enovix Corp cash flow statement, quarters
Line item
Jul 5, 2026 · YTD
Apr 5, 2026 · Q2
Sep 28, 2025 · YTD
Jun 29, 2025 · YTD
Net loss
($81.3M)
($38.3M)
($121.6M)
($67.8M)
Depreciation, accretion and amortization
$19.4M
$9.4M
$26.7M
$17.3M
Stock-based compensation expense
$24.8M
$11.8M
$38.0M
$26.1M
Change in fair value of common stock warrants
($6.6M)
($6.4M)
($11.8M)
($9.9M)
Gain on bargain purchase of assets
$0
—
($4.8M)
($4.8M)
Others
($1.5M)
($386.0K)
$1.3M
$1.4M
Accounts and notes receivables
$5.1M
$4.4M
($2.4M)
($552.0K)
Inventory
($4.2M)
($2.8M)
($7.2M)
($5.4M)
Prepaid expenses and other assets
($1.4M)
($1.3M)
$445.0K
$1.8M
Accounts payable
($3.7M)
($3.6M)
$6.5M
$2.2M
Accrued expenses and compensation
($1.7M)
($4.1M)
($2.8M)
($5.0M)
Deferred revenue
($1.3M)
($736.0K)
$702.0K
$1.0M
Deferred tax liability
($803.0K)
($241.0K)
($1.1M)
($683.0K)
Other liabilities
($1.7M)
($804.0K)
$467.0K
$1.5M
Net cash used in operating activities
($54.9M)
($33.1M)
($68.3M)
($42.8M)
Purchase of property and equipment
($12.8M)
($3.2M)
($17.2M)
($14.2M)
Payment for business acquisition
$0
$0
($10.0M)
($10.0M)
Purchases of investments
($230.1M)
($103.5M)
($370.1M)
($85.5M)
Maturities of investments
$227.6M
$125.0M
$58.1M
$18.6M
Net cash used in investing activities
($15.3M)
$18.3M
($339.2M)
($91.1M)
Proceeds from loan borrowing
$1.3M
—
$360.0M
$0
Proceeds from issuance of common stock under employee stock purchase plan
938.0K
—
711.0K
711.0K
Payroll tax payments for shares withheld upon vesting of RSUs
-3.4M
-1.7M
-4.9M
-2.9M
Purchase of Routejade shares from non-controlling interest
-740.0K
-740.0K
—
—
Repayment of debt
($108.0K)
($55.0K)
($794.0K)
($813.0K)
Proceeds from the exercise of stock options
$0
$0
$3.1M
$782.0K
Payments of transaction costs related to common stock issuance
$0
$0
—
($512.0K)
Net cash used in financing activities
($2.0M)
($2.5M)
$470.7M
($2.7M)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
($202.0K)
($147.0K)
($409.0K)
($102.0K)
Change in cash, cash equivalents, and restricted cash
($72.4M)
($17.3M)
$62.8M
($136.6M)
Cash and cash equivalents and restricted cash, beginning of period
$108.0M
$108.0M
$274.7M
$274.7M
Cash and cash equivalents and restricted cash, end of period
$35.6M
$90.6M
$337.5M
$138.0M
Cash paid for interest
$11.4M
$8.7M
$3.0M
$3.0M
Cash paid for income taxes
$103.0K
$63.0K
$1.1M
$190.0K
Purchase of property and equipment included in liabilities